IFNA1 and thrombotic disease: Plasma sCLEC-2 levels were significantly higher in patients with IFN, or thrombotic diseases, including MVT, ATE, and VTE, than in those with neither thrombotic diseases nor IFN, including those with ITP, ICS, or CLD.